Menu
Search
|

Menu

Close
X

Grifols SA GRLSBN.MC (Madrid SE C.A.T.S.)

18.34 EUR
-0.08 (-0.43%)
As of Jul 16
chart
Previous Close 18.42
Open 18.58
Volume 29,678
3m Avg Volume 78,594
Today’s High 18.58
Today’s Low 18.32
52 Week High 21.30
52 Week Low 16.36
Shares Outstanding (mil) 687.55
Market Capitalization (mil) 15,167.80
Forward P/E 29.70
Dividend (Yield %) 0.14 ( 1.29 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.62 Mean rating from 24 analysts

KEY STATS

Revenue (mm, EUR)
FY18
1,023
FY17
5,376
FY16
5,050
FY15
4,906
EPS (EUR)
FY18
0.210
FY17
1.194
FY16
1.003
FY15
0.716
*Note: Units in Millions of Euro
**Note: Units in Euro

KEY RATIOS

Price to Earnings (TTM)
vs sector
29.70
32.76
Price to Sales (TTM)
vs sector
3.54
5.73
Price to Book (MRQ)
vs sector
4.66
5.45
Price to Cash Flow (TTM)
vs sector
20.64
23.29
Total Debt to Equity (MRQ)
vs sector
172.97
16.72
LT Debt to Equity (MRQ)
vs sector
168.82
12.39
Return on Investment (TTM)
vs sector
5.94
14.61
Return on Equity (TTM)
vs sector
16.00
16.34

EXECUTIVE LEADERSHIP

Victor Grifols Roura
Non-Executive Chairman of the Board, Since 2017
Salary: --
Bonus: --
Victor Grifols Deu
Co-Chief Executive Officer, Executive Director, Since 2017
Salary: --
Bonus: --
Raimon Grifols Roura
Co-Chief Executive Officer, Executive Director, Since 2017
Salary: --
Bonus: --
Thomas Glanzmann
Non-Executive Vice Chairman of the Board, Since 2017
Salary: --
Bonus: --
Alfredo Arroyo Guerra
Chief Financial Officer, Since 2014
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Avinguda de la Generalitat
152, Parque empresarial Can Sant
SANT CUGAT DEL VALLES   BAR   08174

Phone: +34935.712199

Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma for therapeutic use. The Hospital division offers non-biological pharmaceutical products and medical supplies for hospital pharmacy. The Diagnostic division provides clinical analysis and laboratory testing tools to laboratories, hospitals and blood banks. The Raw materials division includes sales of intermediate biological products, as well as manufacturing services to third parties. The Company operates production facilities in Spain, the United States, Mexico and Australia, among others. It controls numerous subsidiaries, such as Kiro Grifols SL.

SPONSORED STORIES